• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机试验中报告的样本量计算和数据分析差异:出版物与方案的比较

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

作者信息

Chan An-Wen, Hróbjartsson Asbjørn, Jørgensen Karsten J, Gøtzsche Peter C, Altman Douglas G

机构信息

Mayo Clinic, Rochester, USA.

出版信息

BMJ. 2008 Dec 4;337:a2299. doi: 10.1136/bmj.a2299.

DOI:10.1136/bmj.a2299
PMID:19056791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2600604/
Abstract

OBJECTIVE

To evaluate how often sample size calculations and methods of statistical analysis are pre-specified or changed in randomised trials.

DESIGN

Retrospective cohort study. Data source Protocols and journal publications of published randomised parallel group trials initially approved in 1994-5 by the scientific-ethics committees for Copenhagen and Frederiksberg, Denmark (n=70).

MAIN OUTCOME MEASURE

Proportion of protocols and publications that did not provide key information about sample size calculations and statistical methods; proportion of trials with discrepancies between information presented in the protocol and the publication.

RESULTS

Only 11/62 trials described existing sample size calculations fully and consistently in both the protocol and the publication. The method of handling protocol deviations was described in 37 protocols and 43 publications. The method of handling missing data was described in 16 protocols and 49 publications. 39/49 protocols and 42/43 publications reported the statistical test used to analyse primary outcome measures. Unacknowledged discrepancies between protocols and publications were found for sample size calculations (18/34 trials), methods of handling protocol deviations (19/43) and missing data (39/49), primary outcome analyses (25/42), subgroup analyses (25/25), and adjusted analyses (23/28). Interim analyses were described in 13 protocols but mentioned in only five corresponding publications.

CONCLUSION

When reported in publications, sample size calculations and statistical methods were often explicitly discrepant with the protocol or not pre-specified. Such amendments were rarely acknowledged in the trial publication. The reliability of trial reports cannot be assessed without having access to the full protocols.

摘要

目的

评估随机试验中样本量计算和统计分析方法预先指定或更改的频率。

设计

回顾性队列研究。数据来源为丹麦哥本哈根和腓特烈斯贝科学伦理委员会于1994 - 1995年最初批准的已发表随机平行组试验的方案和期刊出版物(n = 70)。

主要观察指标

未提供样本量计算和统计方法关键信息的方案和出版物的比例;方案和出版物中呈现的信息存在差异的试验比例。

结果

仅11/62项试验在方案和出版物中完整且一致地描述了现有的样本量计算。37份方案和43份出版物中描述了处理方案偏差的方法。16份方案和49份出版物中描述了处理缺失数据的方法。39/49份方案和42/43份出版物报告了用于分析主要结局指标的统计检验。在样本量计算(18/34项试验)、处理方案偏差的方法(19/43)、缺失数据(39/49)、主要结局分析(25/42)、亚组分析(25/25)和调整分析(23/28)方面,发现方案和出版物之间存在未确认的差异。13份方案中描述了期中分析,但仅在5份相应的出版物中提及。

结论

在出版物中报告时,样本量计算和统计方法通常与方案明显不一致或未预先指定。此类修改在试验出版物中很少得到确认。如果无法获取完整的方案,就无法评估试验报告的可靠性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87e/4787212/066124eacc49/chaa564732.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87e/4787212/066124eacc49/chaa564732.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87e/4787212/066124eacc49/chaa564732.f1.jpg

相似文献

1
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.随机试验中报告的样本量计算和数据分析差异:出版物与方案的比较
BMJ. 2008 Dec 4;337:a2299. doi: 10.1136/bmj.a2299.
2
Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.随机对照试验的亚组分析:基于试验方案和期刊文献的队列研究。
BMJ. 2014 Jul 16;349:g4539. doi: 10.1136/bmj.g4539.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Comparison of protocols and registry entries to published reports for randomised controlled trials.将随机对照试验的方案和注册条目与已发表报告进行比较。
Cochrane Database Syst Rev. 2011 Jan 19;2011(1):MR000031. doi: 10.1002/14651858.MR000031.pub2.
5
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.试验方案与已发表报告中分配隐藏描述的比较:队列研究。
BMJ. 2005 May 7;330(7499):1049. doi: 10.1136/bmj.38414.422650.8F. Epub 2005 Apr 7.
6
Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.在试验方案和相应出版物中关于盲法的报告往往不充分,但很少相互矛盾。
J Clin Epidemiol. 2009 Sep;62(9):967-73. doi: 10.1016/j.jclinepi.2009.04.003.
7
Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials.随机对照试验中缺乏或不充分的亚组分析的理由和报告。
J Clin Epidemiol. 2019 Apr;108:17-25. doi: 10.1016/j.jclinepi.2018.12.009. Epub 2018 Dec 15.
8
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.行业与学术界关于出版权的协议:对随机临床试验方案和出版物的回顾性研究
PLoS Med. 2016 Jun 28;13(6):e1002046. doi: 10.1371/journal.pmed.1002046. eCollection 2016 Jun.
9
[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports].[随机试验中阳性结果的选择性报告——二次发表。方案与已发表报告的比较]
Ugeskr Laeger. 2005 Aug 22;167(34):3189-91.
10
Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.临床试验中分析结果选择性报告及差异的证据:对临床试验队列研究的系统评价
PLoS Med. 2014 Jun 24;11(6):e1001666. doi: 10.1371/journal.pmed.1001666. eCollection 2014 Jun.

引用本文的文献

1
Deep learning in rib fracture imaging: study quality assessment using the Must AI Criteria-10 (MAIC-10) checklist for artificial intelligence in medical imaging.肋骨骨折成像中的深度学习:使用医学成像人工智能的Must AI标准-10(MAIC-10)清单进行研究质量评估。
Insights Imaging. 2025 Aug 9;16(1):173. doi: 10.1186/s13244-025-02046-x.
2
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.《SPIRIT 2025解释与阐述:随机试验方案更新指南》
BMJ. 2025 Apr 28;389:e081660. doi: 10.1136/bmj-2024-081660.
3
Overall Reporting Quality of Randomized Controlled Trials of Acupuncture for Knee Osteoarthritis: A Systematic Review.

本文引用的文献

1
Systematic review of the empirical evidence of study publication bias and outcome reporting bias.关于研究发表偏倚和结果报告偏倚实证证据的系统评价。
PLoS One. 2008 Aug 28;3(8):e3081. doi: 10.1371/journal.pone.0003081.
2
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.临床试验中的选择性报告:对《柳叶刀》接受的试验方案的分析
Lancet. 2008 Jul 19;372(9634):201. doi: 10.1016/S0140-6736(08)61060-0.
3
Protocol review at The Lancet.《柳叶刀》的方案审查
针刺治疗膝骨关节炎随机对照试验的总体报告质量:一项系统评价
J Pain Res. 2024 Oct 16;17:3371-3383. doi: 10.2147/JPR.S477000. eCollection 2024.
4
Reporting Quality of Endoscopic Colorectal Cancer Screening Randomized Controlled Trials: Adherence to Recommendations and Interventions.内镜下结直肠癌筛查随机对照试验的报告质量:对建议和干预措施的遵循情况
Gastro Hep Adv. 2024 Jun 21;3(7):1012-1019. doi: 10.1016/j.gastha.2024.06.003. eCollection 2024.
5
Does renal denervation require cardiovascular outcome-driven data?肾去神经术是否需要心血管结局驱动的数据?
Hypertens Res. 2024 Oct;47(10):2633-2643. doi: 10.1038/s41440-024-01598-7. Epub 2024 Mar 11.
6
Estimating the prevalence of discrepancies between study registrations and publications: a systematic review and meta-analyses.评估研究注册与出版物之间差异的发生率:系统评价和荟萃分析。
BMJ Open. 2023 Oct 4;13(10):e076264. doi: 10.1136/bmjopen-2023-076264.
7
Access to unpublished protocols and statistical analysis plans of randomised trials.获取随机试验未发表的方案和统计分析计划。
Trials. 2022 Aug 17;23(1):674. doi: 10.1186/s13063-022-06641-x.
8
A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.一项对研究伦理委员会批准的试验方案进行的纵向评估:英国遵守 SPIrit 建议研究(ASPIRE-UK)。
Trials. 2022 Jul 27;23(1):601. doi: 10.1186/s13063-022-06516-1.
9
Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review.肺动脉高压特异性治疗临床试验中的亚组分析:一项系统评价
J Pers Med. 2022 May 25;12(6):863. doi: 10.3390/jpm12060863.
10
The new normal? Redaction bias in biomedical science.新常态?生物医学科学中的编辑偏倚。
R Soc Open Sci. 2021 Dec 1;8(12):211308. doi: 10.1098/rsos.211308. eCollection 2021 Dec.
Lancet. 2008 Jul 19;372(9634):189-90. doi: 10.1016/S0140-6736(08)61053-3.
4
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.关于罗非昔布用于治疗阿尔茨海默病或认知障碍试验中的死亡率研究报告:基于罗非昔布诉讼文件的案例分析
JAMA. 2008 Apr 16;299(15):1813-7. doi: 10.1001/jama.299.15.1813.
5
Selective publication of antidepressant trials and its influence on apparent efficacy.抗抑郁药物试验的选择性发表及其对表面疗效的影响。
N Engl J Med. 2008 Jan 17;358(3):252-60. doi: 10.1056/NEJMsa065779.
6
The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?随机对照试验中的意向性分析方法:作者是否言行一致?
Clin Trials. 2007;4(4):350-6. doi: 10.1177/1740774507081223.
7
Discordance between reported intention-to-treat and per protocol analyses.报告的意向性分析与符合方案分析之间的不一致。
J Clin Epidemiol. 2007 Jul;60(7):663-9. doi: 10.1016/j.jclinepi.2006.09.013. Epub 2007 Apr 11.
8
Clinical trial registration--looking back and moving ahead.临床试验注册——回顾与展望
N Engl J Med. 2007 Jun 28;356(26):2734-6. doi: 10.1056/NEJMe078110. Epub 2007 Jun 4.
9
An overview of statistical approaches for adaptive designs and design modifications.适应性设计和设计修改的统计方法概述。
Biom J. 2006 Aug;48(4):507-20. doi: 10.1002/bimj.200510234.
10
Clinical trial registration: transparency is the watchword.临床试验注册:透明度是关键。
Lancet. 2006 May 20;367(9523):1631-3. doi: 10.1016/S0140-6736(06)68708-4.